News &
Events
CORPORATE ANNOUNCEMENTS & PORTFOLIO UPDATES
Stay informed on the latest product launches, regulatory milestones, corporate activities and strategic partnerships from Solaris Pharma Corporation.
News
Featured Article
Solaris Pharma Receives FDA Approval for Clindamycin Phosphate Gel USP, 1% (Twice-A-Day)
July 29, 2020
Solaris Pharma Corporation located Bridgewater, New Jersey announces the final approval from U.S Food and Drug Administration for its
Solaris Pharma Receives FDA Approval for Acyclovir Ointment USP, 5%
April 7, 2020
Solaris Pharma Corporation located Bridgewater, New Jersey announces the final approval from U.S Food and Drug Administration on for its
Solaris Pharma Receives FDA Approval for Clobetasol Propionate Cream USP, 0.05%
January 11, 2019
Solaris Pharma Corporation located in Somerset, New Jersey announces final approval from U.S Food and Drug Administration for its Abbreviated